• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭中心钠肽系统:诊断和治疗意义。

The natriuretic peptide system in heart failure: Diagnostic and therapeutic implications.

机构信息

Department of Cardiovascular Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan.

出版信息

Pharmacol Ther. 2021 Nov;227:107863. doi: 10.1016/j.pharmthera.2021.107863. Epub 2021 Apr 21.

DOI:10.1016/j.pharmthera.2021.107863
PMID:33894277
Abstract

Natriuretic peptides, which are activated in heart failure, play an important cardioprotective role. The most notable of the cardioprotective natriuretic peptides are atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), which are abundantly expressed and secreted in the atrium and ventricles, respectively, and C-type natriuretic peptide (CNP), which is expressed mainly in the vasculature, central nervous system, and bone. ANP and BNP exhibit antagonistic effects against angiotensin II via diuretic/natriuretic actions, vasodilatory actions, and inhibition of aldosterone secretion, whereas CNP is involved in the regulation of vascular tone and blood pressure, among other roles. ANP and BNP are of particular interest with respect to heart failure, as their levels, most notably BNP and N-terminal proBNP-a cleavage product produced when proBNP is processed to mature BNP-are increased in patients with heart failure. Furthermore, the identification of natriuretic peptides as sensitive markers of cardiac load has driven significant research into their physiological roles in cardiovascular homeostasis and disease, as well as their potential use as both biomarkers and therapeutics. In this review, I discuss the physiological functions of the natriuretic peptide family, with a particular focus on the basic research that has led to our current understanding of its roles in maintaining cardiovascular homeostasis, and the pathophysiological implications for the onset and progression of heart failure. The clinical significance and potential of natriuretic peptides as diagnostic and/or therapeutic agents are also discussed.

摘要

利钠肽在心力衰竭中被激活,发挥着重要的心脏保护作用。其中,最显著的心脏保护利钠肽包括心房利钠肽(ANP)和脑利钠肽(BNP),它们分别在心房和心室中大量表达和分泌,而 C 型利钠肽(CNP)主要在血管、中枢神经系统和骨骼中表达。ANP 和 BNP 通过利尿/利钠作用、血管扩张作用和抑制醛固酮分泌对血管紧张素 II 发挥拮抗作用,而 CNP 则参与调节血管张力和血压等作用。ANP 和 BNP 在心力衰竭方面特别引人关注,因为它们的水平,特别是心力衰竭患者中增加的 BNP 和前 BNP 加工成熟 BNP 时产生的 N-末端 proBNP-a 裂解产物,都有所增加。此外,将利钠肽鉴定为心脏负荷的敏感标志物,推动了对其在心血管稳态和疾病中的生理作用及其作为生物标志物和治疗剂的潜在用途的大量研究。在这篇综述中,我讨论了利钠肽家族的生理功能,特别关注了导致我们目前理解其在维持心血管稳态中的作用的基础研究,以及心力衰竭发病和进展的病理生理意义。还讨论了利钠肽作为诊断和/或治疗剂的临床意义和潜力。

相似文献

1
The natriuretic peptide system in heart failure: Diagnostic and therapeutic implications.心力衰竭中心钠肽系统:诊断和治疗意义。
Pharmacol Ther. 2021 Nov;227:107863. doi: 10.1016/j.pharmthera.2021.107863. Epub 2021 Apr 21.
2
Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.利钠肽系统在心力衰竭发病机制中的意义:诊断和治疗重要性。
Pharmacol Ther. 2004 Jun;102(3):223-41. doi: 10.1016/j.pharmthera.2004.04.004.
3
Atrial and brain natriuretic peptides: Hormones secreted from the heart.心房利钠肽和脑利钠肽:从心脏分泌的激素。
Peptides. 2019 Jan;111:18-25. doi: 10.1016/j.peptides.2018.05.012. Epub 2018 May 31.
4
Natriuretic Peptides as Biomarkers: Narrative Review and Considerations in Cardiovascular and Respiratory Dysfunctions.利钠肽作为生物标志物:在心血管和呼吸功能障碍中的叙述性综述及考虑因素。
Yale J Biol Med. 2023 Mar 31;96(1):137-149. doi: 10.59249/NCST6937. eCollection 2023 Mar.
5
The natriuretic peptide system in the brain: implications in the central control of cardiovascular and neuroendocrine functions.大脑中的利钠肽系统:对心血管和神经内分泌功能中枢控制的影响
Front Neuroendocrinol. 1992 Jul;13(3):217-49.
6
Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides.利钠肽的当前生物化学、分子生物学和临床相关性。
J Cardiol. 2011 Mar;57(2):131-40. doi: 10.1016/j.jjcc.2011.01.002. Epub 2011 Feb 5.
7
The renal and cardiovascular effects of natriuretic peptides.利钠肽的肾脏和心血管效应。
Adv Physiol Educ. 2017 Jun 1;41(2):179-185. doi: 10.1152/advan.00177.2016.
8
Angiotensin Receptor-Neprilysin Inhibitors and the Natriuretic Peptide Axis.血管紧张素受体-中性内肽酶抑制剂与利钠肽轴
Curr Heart Fail Rep. 2020 Jun;17(3):67-76. doi: 10.1007/s11897-020-00458-y.
9
The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure.心脏利钠肽测定对心力衰竭诊断和管理的影响。
Clin Chem Lab Med. 2001 Jul;39(7):571-88. doi: 10.1515/CCLM.2001.093.
10
Natriuretic peptides and their therapeutic potential.利钠肽及其治疗潜力。
Heart Dis. 1999 Nov-Dec;1(5):305-28.

引用本文的文献

1
The CNP analogue vosoritide mediates PDE2-sensitive anti-arrhythmogenic effects in mouse hearts with STZ-induced type 1 diabetes.CNP类似物伏索瑞肽在链脲佐菌素诱导的1型糖尿病小鼠心脏中介导对磷酸二酯酶2敏感的抗心律失常作用。
Basic Res Cardiol. 2025 Sep 18. doi: 10.1007/s00395-025-01141-w.
2
Serum interleukin-6, tumour necrosis factor-a, D-dimer after recombinant human brain natriuretic peptide combined with levosimendan in patients with heart failure.重组人脑利钠肽联合左西孟旦治疗心力衰竭患者后血清白细胞介素-6、肿瘤坏死因子-α、D-二聚体水平
J Med Biochem. 2025 Aug 21;44(5):1100-1109. doi: 10.5937/jomb0-56202.
3
Ultrasound-Triggering Carbon Monoxide Release from Rhodium Nanoparticles for Myocardial Infarction Treatment.
超声触发铑纳米颗粒释放一氧化碳用于心肌梗死治疗
ACS Omega. 2025 Aug 26;10(35):40379-40391. doi: 10.1021/acsomega.5c05687. eCollection 2025 Sep 9.
4
Developing a risk score for B-type natriuretic peptide (BNP) ≥ 100 pg/ml levels: the suita study.开发用于B型利钠肽(BNP)≥100 pg/ml水平的风险评分:须田研究
BMC Cardiovasc Disord. 2025 Sep 2;25(1):649. doi: 10.1186/s12872-025-05031-w.
5
From Natriuretic Peptides to microRNAs: Multi-Analyte Liquid Biopsy Horizons in Heart Failure.从利钠肽到微小RNA:心力衰竭中的多分析物液体活检前景
Biomolecules. 2025 Aug 19;15(8):1189. doi: 10.3390/biom15081189.
6
Excessive autophagy of myocardial cells promotes ferroptosis and exacerbates heart failure in the state of myocardial infarction.心肌细胞过度自噬会促进铁死亡,并在心肌梗死状态下加重心力衰竭。
Arch Med Sci. 2024 Jun 12;21(3):944-963. doi: 10.5114/aoms/188719. eCollection 2025.
7
Novel cardiac biomarkers and multiple-marker approach in the early detection, prognosis, and risk stratification of cardiac diseases.新型心脏生物标志物及多标志物方法在心脏病早期检测、预后评估及风险分层中的应用
World J Cardiol. 2025 Jul 26;17(7):106561. doi: 10.4330/wjc.v17.i7.106561.
8
Molecular Insights into the Potential Cardiometabolic Effects of GLP-1 Receptor Analogs and DPP-4 Inhibitors.胰高血糖素样肽-1受体类似物和二肽基肽酶-4抑制剂潜在心脏代谢效应的分子见解
Int J Mol Sci. 2025 Jul 15;26(14):6777. doi: 10.3390/ijms26146777.
9
Relationship Between Changes in Brain Natriuretic Peptide Levels After Initiation of Peritoneal Dialysis and Duration of Peritoneal Dialysis Monotherapy: A Retrospective Observational Study.腹膜透析开始后脑钠肽水平变化与腹膜透析单药治疗持续时间的关系:一项回顾性观察研究。
Cureus. 2025 Jun 16;17(6):e86126. doi: 10.7759/cureus.86126. eCollection 2025 Jun.
10
Pleural Effusion Trajectories and Clinical Outcomes in Cardiac Surgery Patients.心脏手术患者的胸腔积液轨迹及临床结局
Rev Cardiovasc Med. 2025 Jun 26;26(6):37210. doi: 10.31083/RCM37210. eCollection 2025 Jun.